Clinical trial

Combination Chemotherapy Followed by Surgery and Intraperitoneal Chemotherapy in…

NCT00006038 · Memorial Sloan Kettering Cancer Center, Other · Completed

Key facts

NCT number NCT00006038
Title Combination Chemotherapy Followed by Surgery and Intraperitoneal Chemotherapy in Treating Patients With Locally Advanced Stomach Cancer
Official title A Phase II Trial of Neoadjuvant Cisplatin-Fluorouracil-Docetaxel Chemotherapy, Surgery, and Intraperitoneal (IP) Floxuridine (FUdR) Plus Leucovorin in Patients With Locally Advanced Gastric Cancer
Lead sponsor Memorial Sloan Kettering Cancer Center, Other
Collaborators National Cancer Institute (NCI) NIH
Status Completed
Phase Phase 2
Study type Interventional
Conditions Esophageal Cancer, Gastric Cancer
Intervention type Drug, Procedure
Interventions cisplatin, docetaxel, floxuridine, fluorouracil, leucovorin calcium, conventional surgery
Start date Feb 1, 2000
Primary completion Feb 1, 2003
Completion Feb 1, 2003
First posted Feb 12, 2004
Last update posted Jun 19, 2013
Countries United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies